Technology
Health
Pharmaceutical

Cyclerion Therapeutics

$8.85
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.73 (8.99%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell CYCN and other stocks, options, ETFs, and crypto commission-free!

About CYCN

Cyclerion Therapeutics, Inc. engages in the discovery, development, and commercialization of treatments for serious and orphan diseases, through the use of soluble guanylate cyclase (sGC) pharmacology. Its product pipeline includes several sGC stimulators. Read More The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.

Employees
143
Headquarters
Cambridge, Massachusetts
Founded
2018
Market Cap
242.68M
Price-Earnings Ratio
Dividend Yield
Average Volume
57.04K
High Today
$9.07
Low Today
$8.14
Open Price
$8.14
Volume
117.24K
52 Week High
$22.85
52 Week Low
$7.83

Collections

Technology
Health
Pharmaceutical
Therapy
2019 IPO
US
North America

CYCN Earnings

-$1.36
-$1.30
-$1.24
-$1.18
Q1 2019
Q2 2019
Estimated
Actual
-$1.18 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.